At MCPF we talk a lot about our global approach to spinal cord injury research and how it takes a lot of time. During this episode of Spinal Cast Helen-Marie Dunmore, Principal Scientific Advisor with Charles River Laboratories, United Kingdom shares some insight on why it takes so long and how their work is critical for safe and reliable therapies for those affected by spinal cord injury. We discuss the role of regulation, new drug trials, blood brain barrier, data sets, pre-clinical testing, animal models, functional methods, collaboration, and standardization – just to name a few of the challenges. We also hear about the promising therapeutic targets that Helen-Marie is especially excited about; protection and regeneration of neurons, tissue repair, cell and gene-based therapies. Yep, it all takes time, a lot of time, and money.The work that Helen-Marie and others at Charles River do is behind the scenes but without it we would not have the data or safety measures in place that guarantee advancement in the scientific field of spinal cord injury. Thanks for your devotion and work! A detailed bio for Helen-Marie Dunmore can be found at the link below:https://www.criver.com/about-us/about-us-overview/our-employees/employees/helen-marie-dunmore-ertCharles River Laboratories: https://www.criver.com/ Thanks again to Helen-Marie for being our guest on today's podcast! This production is a collaborative effort of volunteers working to create a quality audio and visual experience around the subject of spinal cord injury. A special shout out of appreciation to Clientek for providing studio space and top-notch recording equipment. Most importantly, thank YOU for being part of the Spinal Cast audience!Interested in watching these episodes?! Check out our YouTube playlist! - https://youtube.com/playlist?list=PL40rLlxGS4VzgAjW8P6Pz1mVWiN0Jou3vIf you'd like to learn more about the Morton Cure Paralysis Fund you can visit our website at - https://mcpf.org/Donations are always appreciated - https://mcpf.org/you-can-help/